Mangalam Drugs & Organics Q1, Q2, Q3, Q4, FY 2017-18, FY 2016-17 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Mangalam Drugs & Organics Company Profile :

Mangalam Drugs and Organics Limited is an Indian company engaged in the business of manufacturing of drugs, medicines and allied products.

Company also manufactures active pharmaceutical ingredients (APIs), intermediates and specialty chemicals.

Company has a range of products that involves various chemistries, including Acylations, Polymoph Transformations, Chlorination and Hydride Reductions.


Mangalam Drugs & Organics ResultsBSE Code : 532637
NSE Symbol :  MANGALAM
ISIN No. : INE584F01014
Industry : Pharmaceuticals
Face Value : Rs. 10.00


If you are an investor who has shares of Mangalam Drugs & Organics or you are an stock market analyst then i am sure you might for Quarterly Results of Mangalam Drugs & Organics.

In this article you will find Q1, Q2, Q3, Q4 and FY 2017-18 Results of Mangalam Drugs & Organics . That’s not all, you can compare those results with previous year i.e., FY 2016-17 Results of Mangalam Drugs & Organics .

Mangalam Drugs & Organics Q1 Results 2017-18 :

Mangalam Drugs & Organics will announce its Q1 FY 2017-18 Results in August 2017. Will soon update the below mentioned table.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Mangalam Drugs & Organics will announce its Q2 FY 2017-18 Results in the month of October 2017.

(Values in Cr.) Q2 Standalone Q2 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Mangalam Drugs & Organics will announce its Q3 FY 2017-18 Results in the month of January 2018.

(Values in Cr.) Q3 Standalone Q3 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Mangalam Drugs & Organics will announce its Q4 FY 2017-18 Results in the month of April 2018.

(Values in Cr.) Q4 Standalone Q4 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Mangalam Drugs & Organics will announce its FY 2017-18 Results in the month of April 2018.

(Values in Cr.) FY 2017-18 Standalone FY 2017-18 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Note : We will update the results table above as and when results are announced. Visit again.

Mangalam Drugs & Organics Previous Year’s Results (FY 2016-17) :

(Values in Cr.) FY 2016-17 Standalone FY 2016-17 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Note : If you like this information about Mangalam Drugs & Organics Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.